Status:
NOT_YET_RECRUITING
Registry of Local Recurrences After Breast-conserving Surgery
Lead Sponsor:
Universidade do Porto
Collaborating Sponsors:
Centro Hospitalar Universitário São João, EPE
Conditions:
Breast Cancer Recurrent
Eligibility:
FEMALE
18+ years
Brief Summary
The ReLoCC project is a prospective, multicenter, clinical study to register cases of local recurrence after breast-conserving surgery, in centers dedicated to the treatment of breast cancer, in Portu...
Eligibility Criteria
Inclusion
- Female patients
- Age \> 18 years
- Patients who have previously undergone breast-conserving surgery as part of the treatment of invasive or non-invasive (in situ) breast cancer
- and adjuvant breast RT: total (WBI) or partial (PBI)
- without adjuvant radiotherapy to the breast
- Recent histological diagnosis of homolateral, invasive or non-invasive (in situ) breast carcinoma
Exclusion
- Male
- Age \< 18 years
- Stage 4 at diagnosis
- Patients operated outside the participating Centers and for whom it is not possible to obtain complete information regarding the primary treatment
- History of other primary invasive malignant tumor (except non-melanoma skin carcinomas)
- Patients already treated for another local recurrence of breast carcinoma
- Absence of clinical follow-up and records in clinical process
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT05406661
Start Date
December 1 2023
End Date
December 1 2026
Last Update
October 19 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.